A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
Clinical trial NCT02932943 · COMPLETED
Trial details
- NCT number
- NCT02932943
- Sponsor
- Naurex, Inc, an affiliate of Allergan plc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-15
- Primary completion
- 2018-09-21
- Enrollment
- 465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.